SCR-LIP-000607 · Claim · machine-readable JSON →

Ultrasound, body-composition and lymphatic imaging measures are reported to discriminate lipedema from controls or related conditions.

General proposition consolidated from 8 earlier single-paper claims; each study's own result is shown as its finding.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
low (GRADE)
Evidence
8 source(s) · by Amato
Dates
2026-11-20 → 2026-11-20

Structured evidence, machine-compiled — not a verdict.

Evidence over time

20192026Lipedema and Dercum's Disease: A New Application of Bioimpedance — Crescenzi et al. (2019) · consistentThe role of IL-6 gene polymorphisms in the risk of lipedema — Di Renzo L et al. (2020) · consistentUltrasound criteria for lipedema diagnosis — Amato et al. (2021) · consistentBody Composition Assessment by Dual-Energy X-Ray Absorptiometry: A Useful Tool for the Diagnosis of Lipedema — Buso et al. (2022) · consistentReply letter to the editor regarding ultrasound examination for en-suite measurements in lipedema — Amato & Saucedo (2022) · consistentLower Limb Lipedema–Superficial Lymph Flow, Skin Water Concentration, Skin and Subcutaneous Tissue Elasticity — Zaleska et al. (2023) · consistentLipedema: pathophysiological insights and therapeutic strategies — An update for dermatologists (2026) · refiningLymphoscintigraphic Findings in Patients With Lipedema: A Systematic Review. — Mortada H, Alsaif MA, AlJohani A, Altuwaijri AM, Alshomer F. (2026) · refining

Evidence (8)

Context (PECO)

Populationwomen evaluated for limb fat/obesity
Conditionlipedema
ExposureBMI-only obesity classification
Comparatorfat-distribution-aware assessment
Outcomeunderdiagnosis of lipedema
Scopediagnostic reasoning

Answers these questions

Gaps & caveats

Change log